跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ESCITALOPRAM GRINDEKS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ESCITALOPRAM GRINDEKS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
ESCITALOPRAM GRINDEKS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Grindeks As
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 9, 2023
Approval ID
f8a4b9bc454788b7
Company
Grindeks As
Type
Standard
Approval Details
Approval Id
f8a4b9bc454788b7
Drug Cima Aemps Name
ESCITALOPRAM GRINDEKS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
89007
Holder Company Name
Grindeks As
Marketing Company Name
Grindeks Kalceks Espana S.L.
Holder Company Detail Path
/organization/grindeks-as
Authorization Date
2023-08-09
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Grindeks As
Company Detail Path
/organization/grindeks-as
Company Information
Pharmaceutical Company Name
Grindeks AS
Country Name
Latvia
Website
http://grindeks.eu
Active Ingredients
ESCITALOPRAM OXALATO
25,552 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 9, 2023
Approval ID
f8a4b9bc454788b7
Type
Standard
Back to CIMA-AEMPS Approvals